Variant report
Variant | nsv980477 |
---|---|
Chromosome Location | chr4:131129564-131132630 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534186427 | chr4:131129602-131129603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs35943954 | chr4:131129632-131129633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181649803 | chr4:131129649-131129650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138018296 | chr4:131129653-131129654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374067490 | chr4:131129666-131129667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537783617 | chr4:131129674-131129675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs28587640 | chr4:131130035-131130036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76608326 | chr4:131130059-131130060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571681520 | chr4:131130108-131130109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558100523 | chr4:131130166-131130167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545411716 | chr4:131130188-131130189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149497490 | chr4:131130213-131130214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79848798 | chr4:131130249-131130250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551040672 | chr4:131130260-131130261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs534240700 | chr4:131130314-131130315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555885794 | chr4:131130329-131130330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563089987 | chr4:131130374-131130375 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs530238149 | chr4:131130381-131130382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372544447 | chr4:131130402-131130403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548613384 | chr4:131130430-131130431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574230142 | chr4:131130462-131130463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566991133 | chr4:131130464-131130465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534148143 | chr4:131130486-131130487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564969706 | chr4:131130538-131130539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs17050899 | chr4:131130583-131130584 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs148681367 | chr4:131130595-131130596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187309195 | chr4:131130606-131130607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201607438 | chr4:131130633-131130634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192422918 | chr4:131130641-131130642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs78631280 | chr4:131130681-131130682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs117170838 | chr4:131130713-131130714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183814061 | chr4:131130743-131130744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576968567 | chr4:131130829-131130830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571794674 | chr4:131130854-131130855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545523254 | chr4:131130877-131130878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186807958 | chr4:131130975-131130976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189701648 | chr4:131130980-131130981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563738369 | chr4:131131028-131131029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575997295 | chr4:131131048-131131049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs544847837 | chr4:131131059-131131060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563040654 | chr4:131131071-131131072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141369492 | chr4:131131085-131131086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74906951 | chr4:131131121-131131122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560700858 | chr4:131131131-131131132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200239651 | chr4:131131140-131131141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147239630 | chr4:131131174-131131175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570849534 | chr4:131131233-131131234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531612529 | chr4:131131277-131131278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550021538 | chr4:131131303-131131304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78310179 | chr4:131131373-131131374 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:131129600-131129800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr4:131130000-131131800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr4:131131600-131131800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr4:131131600-131132600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr4:131131600-131133200 | Enhancers | NHDF-Ad | bronchial |
6 | chr4:131131800-131132200 | Enhancers | NH-A | brain |
7 | chr4:131131800-131132400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr4:131131800-131132400 | Enhancers | Adipose Nuclei | Adipose |
9 | chr4:131131800-131132400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr4:131131800-131132600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr4:131131800-131132600 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr4:131131800-131132600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr4:131131800-131132600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
14 | chr4:131131800-131132600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr4:131132000-131132400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr4:131132200-131132600 | Enhancers | Dnd41 | blood |
17 | chr4:131132600-131133000 | Weak transcription | Dnd41 | blood |
18 | chr4:131132600-131133200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr4:131132600-131133600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |